| Who Should Attend: Behavioral Health Professionals
Description: The landscape of psychoactive substances is evolving faster than regulatory frameworks can keep pace. From semi-synthetic cannabinoids like Delta-8 to kratom-derived 7-OH, tianeptine, and nitrous oxide, behavioral health professionals are increasingly encountering clients who use substances that exist in legal gray zones, carry significant health risks, and are poorly understood by both the public and many clinicians. Join Dr. Aaron Weiner for an evidence-based overview of the most prevalent unregulated and semi-regulated psychoactive substances currently available at retail outlets, including their pharmacology, health risks, addiction potential, and regulatory status. Attendees will also explore practical, motivation-based clinical strategies and best practices for engaging clients who use these substances, moving beyond fact-delivery toward values-aligned conversations that build genuine readiness for change.
Cameron McNamee, Director of Policy and Communications from the Ohio Board of Pharmacy, will provide an Ohio perspective, including current state and local considerations, an overview of the regulatory landscape, and areas where gaps or challenges may still exist. His presentation will help connect the national trends discussed by Dr. Weiner to what behavioral health professionals are seeing and navigating here in Ohio.
|
